AG-13958

CAS No. 319460-94-1

AG-13958( AG-013958 )

Catalog No. M20778 CAS No. 319460-94-1

AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 275 In Stock
5MG 264 In Stock
10MG 407 In Stock
25MG 655 In Stock
50MG 923 In Stock
100MG 1228 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AG-13958
  • Note
    Research use only, not for human use.
  • Brief Description
    AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
  • Description
    AG-13958 (AG-013958) a potent VEGFR tyrosine kinase inhibitor for the treatment of age-related macular degeneration.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AG-013958
  • Pathway
    Angiogenesis
  • Target
    VEGFR
  • Recptor
    VEGFR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    319460-94-1
  • Formula Weight
    467.5
  • Molecular Formula
    C26H22FN7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:5 mg/mL (10.70 mM)
  • SMILES
    Cc1cc(C(=O)Nc2cc(Nc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)ccc2F)n(C)n1
  • Chemical Name
    N-[2-Fluoro-5-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]amino]phenyl]-13-dimethyl-1H-pyrazole-5-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Barakat M R Kaiser P . VEGF inhibitors for the treatment of neovascular age-related macular degeneration[J]. Expert Opinion on Investigational Drugs 2009 18(5):637-646.
molnova catalog
related products
  • Regorafenib

    A potent multikinase inhibitor that potently inhibits these endothelial cell kinases in biochemical and cellular kinase phosphorylation assays with nanomolar range (IC50=3-200 nM).

  • DMH4

    DMH4 is a potent and selective inhibitor of VEGFR2 with an IC50 of 0.16 μM.

  • Apatinib Mesylate

    Apatinib (YN968D1) is a multitargeted tyrosine kinase inhibitor (TKI) that inhibits VEGFR-2 (Flk-1/KDR, IC50=1 nM), RET, c-Kit and c-Src (IC50=13, 429 and 530 nM respectively).